Drug Granted Accelerated Approval for Rare Duchenne Muscular Dystrophy Mutation

THURSDAY, Aug. 13, 2020 — Accelerated approval has been granted to Viltepso (viltolarsen) injection for treatment of patients with Duchenne muscular dystrophy (DMD) and a mutation of the DMD gene amenable to exon 53 skipping, the U.S. Food and Drug…
Source: Topamax